Literature DB >> 19232812

Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: results from a prospective multicentric study in Italy.

F Parazzini1, V Mais, S Cipriani, M Busacca, P Venturini.   

Abstract

OBJECTIVE: We conducted a cross-sectional study on the frequency and risk factors for adenomyosis in women who underwent hysterectomy for benign gynecological conditions. STUDY
DESIGN: All women who consecutively underwent hysterectomy during the study period for benign gynecological conditions at 18 gynecological departments were eligible for the study. A total of 820 women entered the study. Pathological data were collected prospectically.
RESULTS: Adenomyosis was identified in 231 women (28.2%, 95% confidence interval, CI, 24.6-32.5). The frequency of adenomyosis was similar in women with indication for surgery fibroids/menorrhagia (143 cases, 28.5%) or genital prolapse (69 cases, 28.2%). The rate ratio (RR) of adenomyosis was 1.9 (95% CI 1.2-2.8) in women reporting one or more induced abortions, in comparison with those reporting no induced abortion. Women with adenomyosis reported more frequently dysmenorrhoea and chronic pelvic pain, but not dyspareunia.
CONCLUSIONS: This study shows that adenomyosis is common in women who undergo hysterectomy and that it is more frequent among women reporting induced abortions dysmenorrhoea and chronic pelvic pain.

Entities:  

Mesh:

Year:  2009        PMID: 19232812     DOI: 10.1016/j.ejogrb.2008.12.010

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  17 in total

1.  Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study.

Authors:  F Andrei Taran; Amy L Weaver; Charles C Coddington; Elizabeth A Stewart
Journal:  Hum Reprod       Date:  2010-02-22       Impact factor: 6.918

2.  Perioperative Suppression of Schwann Cell Dedifferentiation Reduces the Risk of Adenomyosis Resulting from Endometrial-Myometrial Interface Disruption in Mice.

Authors:  Xi Wang; Xishi Liu; Sun-Wei Guo
Journal:  Biomedicines       Date:  2022-05-24

3.  Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy.

Authors:  F A Taran; E A Stewart; S Brucker
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

4.  The effect of adenomyosis on the outcomes of laparoscopic hysterectomy.

Authors:  Ali Yavuzcan; Alper Başbuğ; Merve Baştan; Mete Çağlar; İsmail Özdemir
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-09-01

5.  The clinical significance of classical and new emerging determinants of adenomyosis.

Authors:  Serkan Bodur; Ozgur Dundar; Mine Kanat Pektas; Mustafa Alparslan Babayigit; Okan Ozden; Zafer Kucukodacı
Journal:  Int J Clin Exp Med       Date:  2015-05-15

6.  Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens.

Authors:  Seza Tetikkurt; Elif Çelik; Hazal Taş; Tuğçe Cay; Selman Işik; Abdullah Taner Usta
Journal:  Mol Clin Oncol       Date:  2018-06-18

7.  Anatomic Sites and Associated Clinical Factors for Deep Dyspareunia.

Authors:  Paul J Yong; Christina Williams; Ali Yosef; Fontayne Wong; Mohamed A Bedaiwy; Sarka Lisonkova; Catherine Allaire
Journal:  Sex Med       Date:  2017-08-01       Impact factor: 2.491

8.  Characterization of patients that can continue conservative treatment for adenomyosis.

Authors:  Chiho Miyagawa; Kosuke Murakami; Takako Tobiume; Takafumi Nonogaki; Noriomi Matsumura
Journal:  BMC Womens Health       Date:  2021-12-28       Impact factor: 2.809

Review 9.  Origin and Pathogenic Mechanisms of Uterine Adenomyosis: What Is Known So Far.

Authors:  Christina Anna Stratopoulou; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Reprod Sci       Date:  2020-10-22       Impact factor: 3.060

10.  How to evaluate adenomyosis in patients affected by endometriosis?

Authors:  Nadine Di Donato; Renato Seracchioli
Journal:  Minim Invasive Surg       Date:  2014-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.